Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders.

Joanna J. Arch, Georg H. Eifert, Carolyn Davies, Jennifer Plumb Vilardaga, Raphael D. Rose, Michelle G. Craske

Journal of Consulting and Clinical Psychology · 2012 · 433 citations · 53 references

DOIFull text

Open access

Concepts

TL;DR

Randomized comparisons of acceptance-based treatments with traditional CBT for anxiety disorders are lacking. The study compared ACT to CBT for heterogeneous anxiety disorders in 128 adults with at least one DSM‑IV anxiety disorder, both treatments including behavioral exposure. Assessments at pre‑treatment, post‑treatment, and 6‑ and 12‑month follow‑up measured anxiety‑specific and non‑anxiety‑specific outcomes, while also evaluating treatment adherence, therapist competency, credibility, and comorbid mood/anxiety disorders. Both ACT and CBT produced similar pre‑to‑post improvements, but ACT yielded steeper CSR gains and lower CSRs at 12‑month follow‑up, higher AAQ scores, while CBT achieved higher QOLI; overall outcomes were comparable, supporting ACT as a viable anxiety disorder treatment.

Abstract

Randomized comparisons of acceptance-based treatments with traditional cognitive behavioral therapy (CBT) for anxiety disorders are lacking. To address this gap, we compared acceptance and commitment therapy (ACT) to CBT for heterogeneous anxiety disorders.One hundred twenty-eight individuals (52% female, mean age = 38, 33% minority) with 1 or more DSM-IV anxiety disorders began treatment following randomization to CBT or ACT; both treatments included behavioral exposure. Assessments at pre-treatment, post-treatment, and 6- and 12-month follow-up measured anxiety-specific (principal disorder Clinical Severity Ratings [CSRs], Anxiety Sensitivity Index, Penn State Worry Questionnaire, Fear Questionnaire avoidance) and non-anxiety-specific (Quality of Life Index [QOLI], Acceptance and Action Questionnaire-16 [AAQ]) outcomes. Treatment adherence, therapist competency ratings, treatment credibility, and co-occurring mood and anxiety disorders were investigated.CBT and ACT improved similarly across all outcomes from pre- to post-treatment. During follow-up, ACT showed steeper linear CSR improvements than CBT (p < .05, d = 1.26), and at 12-month follow-up, ACT showed lower CSRs than CBT among completers (p < .05, d = 1.10). At 12-month follow-up, ACT reported higher AAQ than CBT (p = .08, d = 0.42; completers: p < .05, d = 0.56), whereas CBT reported higher QOLI than ACT (p < .05, d = 0.42). Attrition and comorbidity improvements were similar; ACT used more non-study psychotherapy at 6-month follow-up. Therapist adherence and competency were good; treatment credibility was higher in CBT.Overall improvement was similar between ACT and CBT, indicating that ACT is a highly viable treatment for anxiety disorders.

References

53